Firestone Karen 4
4 · Amylyx Pharmaceuticals, Inc. · Filed Mar 20, 2023
Insider Transaction Report
Form 4
Firestone Karen
Director
Transactions
- Purchase
Common Stock
2023-03-16$31.99/sh+1,000$31,990→ 1,000 total - Award
Stock Option (Right to Buy)
2023-03-16+27,403→ 27,403 totalExercise: $32.08Exp: 2033-03-16→ Common Stock (27,403 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.96 to $32.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request
- [F2]One-third of the shares subject to the option shall vest on the first anniversary of the date of grant, and the remaining two-thirds will vest in equal monthly installments over two years, provided, however, that all vesting shall cease if the director resigns from the Board or otherwise ceases to serve as a director of the Issuer.